A Prospective, Multicenter, Open-label Trial of Zoledronic Acid in Patients with Hormone Refractory Prostate Cancer

PURPOSE: The short-term safety and efficacy of zoledronic acid for the treatment of skeletal metastasis was evaluated in patients with hormone-refractory prostate cancer. PATIENTS AND METHODS: A total of 19 hormone-refractory prostate cancer patients with bone metastases were enrolled. All patients...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Hong, Sung Joon, Cho, Kang Su, Choi, Han Yong, Ahn, Hanjong, Kim, Choung-Soo, Chung, Byung Ha
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Yonsei University College of Medicine 2007
Aiheet:
Original Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC2628173/
https://ncbi.nlm.nih.gov/pubmed/18159593
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3349/ymj.2007.48.6.1001
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia